Skip to content

Pulsatility of femoral vein and lung ultrasound guide stop fluid resuscitation: A randomized control trial

Pulsatility of femoral vein and lung ultrasound guide stop fluid resuscitation: A randomized control trial

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
TCTR
Registry ID
TCTR20251123003
Enrollment
86
Registered
2025-11-23
Start date
2025-12-01
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Septic shock Shock, Septic Ultrasonography Fluid Therapy

Interventions

Participants in the intervention group will receive fluid management guided by bedside lung ultrasound and femoral vein Doppler. These ultrasound assessments are used to detect signs of congestion and
Ultrasound-guided fluid management,standard care

Sponsors

Ramathibodi hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: 1.Adults aged 18 years or older 2.Septic shock with mean arterial pressure less than 65 mmHg and signs of poor tissue perfusion (such as delayed capillary refill, altered consciousness, or oliguria) 3.Endotracheal intubation 4.Admission to ICU within 48 hours

Exclusion criteria

Exclusion criteria: 1.Clinical evidence of volume overload, including pulmonary edema or tissue edema 2.Pregnancy 3.Patients who refuse fluid resuscitation, vasopressor therapy, or endotracheal intubation 4.Requirement for immediate surgery 5.Participation in another clinical study 6.Contraindications to lung ultrasound, such as open chest wound, rib fractures, extensive subcutaneous emphysema, or severe skin infection at probe site

Design outcomes

Primary

MeasureTime frame
Change in SOFA score from baseline to 72 hours 72 hours after randomization Point difference in SOFA score

Secondary

MeasureTime frame
28-day Mortality 28 days Percentage of participants who died,28-day Vasopressor-Free Days 28 days Number of days alive and free from vasopressor support within 28 days,Total Fluid Administered 72 hr 72 hr Total intravenous fluid volume administered in 72 hr,Time to Vasopressor Initiation From randomization to initiation of vasopressor therapy Time (in hours) from study randomization until the first administration of any,Development of Pulmonary Edema During ICU stay Presence/absence (Yes/No),Length of ICU Stay From randomization to ICU discharge Days,Incidence of Acute Kidney Injury (AKI) During ICU stay Number and percentage of participants with AKI

Countries

Thailand

Contacts

Public ContactPachara Saengngammongkhol

Ramathibodi Hospital

phat19941994@gmail.com022011301

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 10, 2026